Work

One-Week Kava Dietary Supplementation Increases Both Urinary N- and O-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers

Year: 2024

Type: article

Study design: Clinical Trial

Source: Chemical Research in Toxicology

DOI: 10.1021/acs.chemrestox.4c00109

Authors: Qi Hu, Zhixin Tang, Allison Lynch, Breanne Freeman, Naomi Fujioka, Ramzi G. Salloum, John Malaty, Frank A. Orlando, Taimour Langaee, Zhiguang Huo, Chengguo Xing

Institutions: University of Florida, University of Florida Health, University of Minnesota

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Florida Department of Health, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, National Center for Advancing Translational Sciences, National Center for Complementary and Integrative Health

Awards: G1236510564, Together: Transforming and Translating Discovery to Improve Health, G2698398778, G3345260134, The potential of kava in enabling tobacco cessation - its holistic effects in managing stress and insomnia associated with abstinence, Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation, G7915048140

OpenAlex ID: W4400613145

FWCI: 1.091

Cites: 32

Cited by: 3

Related to: 10